Huawei Zou
- Molecular Biology
- Cancer Research top 5%
- Oncology top 10%
- Pulmonary and Respiratory Medicine
- Pathology and Forensic Medicine
- Topics
- MicroRNA in disease regulation (6 papers)Lung Cancer Treatments and Mutations (6 papers)Epigenetics and DNA Methylation (4 papers)
- Journals
- SHILAP Revista de lepidopterologíaPLoS ONEThe FASEB Journal
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Huawei Zou
36 papers receiving 702 citations
Peers
Comparison fields: 5 of 69
- Molecular Biology 403
- Cancer Research 322
- Oncology 244
- Pulmonary and Respiratory Medicine 163
- Pathology and Forensic Medicine 70
Countries citing papers authored by Huawei Zou
This map shows the geographic impact of Huawei Zou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huawei Zou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huawei Zou more than expected).
Fields of papers citing papers by Huawei Zou
This network shows the impact of papers produced by Huawei Zou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huawei Zou. The network helps show where Huawei Zou may publish in the future.
Co-authorship network of co-authors of Huawei Zou
This figure shows the co-authorship network connecting the top 25 collaborators of Huawei Zou. A scholar is included among the top collaborators of Huawei Zou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huawei Zou. Huawei Zou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 3 | |
| 3 | 4 | |
| 4 | 17 | |
| 5 | 2 | |
| 6 | 1 | |
| 7 | 51 | |
| 8 | 19 | |
| 9 | 6 | |
| 10 | 6 | |
| 11 | 27 | |
| 12 | 32 | |
| 13 | 33 | |
| 14 | 3 | |
| 15 | 23 | |
| 16 | 60 | |
| 17 | 8 | |
| 18 | 14 | |
| 19 | 2 | |
| 20 | Radiosensitivity enhanced by recombinant adenovirus p53 in lung adenocarcinoma | 1 |
About Huawei Zou
Huawei Zou is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 36 papers that have together received 710 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (6 papers), Lung Cancer Treatments and Mutations (6 papers) and Epigenetics and DNA Methylation (4 papers). The work is most often cited by research in Cancer Research (322 citations), Oncology (244 citations) and Molecular Biology (403 citations). Huawei Zou has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Cheng‐Bo Han, Jie‐Tao Ma, Kai Li, Shunchao Yan, Xin Jiao, Cheng Sun, Heying Zhang, Fan Li, Yuexian Li and Kexin Jiang. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and The FASEB Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.